ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 1 filers reported holding ASCENDIS PHARMA A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,637 | +2931.5% | 17,482 | +2775.3% | 0.00% | – |
| Q2 2023 | $54 | -99.3% | 608 | -99.1% | 0.00% | -100.0% |
| Q1 2023 | $7,388 | +6.7% | 68,902 | +21.5% | 0.00% | 0.0% |
| Q4 2022 | $6,926 | -99.9% | 56,707 | -54.6% | 0.00% | -78.6% |
| Q3 2022 | $12,889,000 | -4.4% | 124,821 | -13.9% | 0.01% | +75.0% |
| Q2 2022 | $13,483,000 | +13118.6% | 145,044 | +16668.1% | 0.01% | – |
| Q1 2022 | $102,000 | -39.3% | 865 | -31.0% | 0.00% | – |
| Q4 2021 | $168,000 | -98.6% | 1,254 | -98.3% | 0.00% | -100.0% |
| Q3 2021 | $11,637,000 | +12830.0% | 73,009 | +10558.2% | 0.01% | – |
| Q2 2021 | $90,000 | -82.7% | 685 | -83.0% | 0.00% | – |
| Q1 2021 | $520,000 | -28.1% | 4,039 | -6.9% | 0.00% | – |
| Q4 2020 | $723,000 | +13.7% | 4,337 | +5.2% | 0.00% | – |
| Q3 2020 | $636,000 | +8.0% | 4,121 | +3.5% | 0.00% | – |
| Q2 2020 | $589,000 | +1491.9% | 3,983 | +1110.6% | 0.00% | – |
| Q1 2020 | $37,000 | -28.8% | 329 | -13.0% | 0.00% | – |
| Q4 2019 | $52,000 | -93.7% | 378 | -95.6% | 0.00% | -100.0% |
| Q3 2019 | $829,000 | +2338.2% | 8,611 | +2789.6% | 0.00% | – |
| Q2 2019 | $34,000 | -99.9% | 298 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $24,259,000 | +559.2% | 206,111 | +250.9% | 0.02% | +466.7% |
| Q4 2018 | $3,680,000 | +933.7% | 58,733 | +1070.0% | 0.00% | – |
| Q3 2018 | $356,000 | +9.5% | 5,020 | +2.8% | 0.00% | – |
| Q2 2018 | $325,000 | -5.8% | 4,883 | -7.2% | 0.00% | – |
| Q1 2018 | $345,000 | +83.5% | 5,260 | +11.9% | 0.00% | – |
| Q4 2017 | $188,000 | +3.9% | 4,700 | -6.0% | 0.00% | – |
| Q3 2017 | $181,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |